<DOC>
	<DOCNO>NCT00581828</DOCNO>
	<brief_summary>The purpose perform one-year study design ass whether treatment hypovitaminosis D increase intestinal absorption calcium , subsequent retention calcium within bone , decrease bone turnover , favorably impact upon skeletal muscle mass , functional status , measure physical function quality life . I hypothesize treatment hypovitaminosis D result improve intestinal calcium absorption , great retention calcium within bone reservoir improve physical function , quality life muscle mass .</brief_summary>
	<brief_title>Does Treatment Hypovitaminosis D Increase Calcium Absorption ?</brief_title>
	<detailed_description>Postmenopausal woman vitamin D insufficiency participate one-year study . We study change intestinal calcium absorption baseline ( vitamin D insufficiency ) follow ( vitamin D repletion whether increase absorption result subsequent increased retention calcium within bone one-year interval measure bone densitometry . We also study effect vitamin D repletion upon whole body muscle mass , quality life physical function . A review medical record screen visit determine eligibility . Eligible consent subject present GCRC early morning follow baseline lab , consume breakfast glass orange juice enrich stable calcium isotope , receive 3 mg another stable calcium isotope intravenous injection . Over next eight hour , blood take total 9 time first 24 hour , urine stool collect measurement calcium content . Subsequently next five day , woman collect three urine specimen daily . Women receive vitamin D treat vitamin D deficiency . Once vitamin D repletion accomplish , woman repeat 24-hour visit subsequent five-day urine collection . Women maintain vitamin D repletion take twice monthly tablet ( 50,000 IU ) vitamin D2 . To confirm vitamin D repletion safety full one year study , additional study visit occur 3 , 6 12 month . A bone density test screen twelve month allow u assess effect vitamin D repletion whole body bone mass skeletal mass . At GCRC stay , 3 , 6 12 month , woman complete questionnaire regard quality life functional status perform Timed Up Go Test . Because wish maintain confirm constant calcium intake throughout one- year study , woman complete calcium questionnaire baseline , 3 , 6 12 month . With subject 's consent , collect one tube blood isolate DNA . When sufficient knowledge available regard pathophysiologic mechanism whereby genetic polymorphism impact calcium homeostasis , test DNA polymorphism relate genetic information data collect calcium homeostasis .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Hypoparathyroidism</mesh_term>
	<mesh_term>Avitaminosis</mesh_term>
	<mesh_term>Hypercalcemia</mesh_term>
	<mesh_term>Rickets</mesh_term>
	<mesh_term>Hypercalciuria</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<criteria>woman least five year past onset menopause , define date last menses serum 25 ( OH ) D 1624 ng/ml reverse phase HPLC calcium intake &lt; = 1,100 mg daily Intake &gt; 1,100 mg calcium per day combination diet supplement Hypercalcemia ( baseline serum calcium normal reference range ) Nephrolithiasis , document medical record patient report Inflammatory bowel disease , malabsorption , chronic diarrhea , use antibiotic within past month Creatinine &gt; 2.0 mg/dL Hypercalciuria ( baseline urine calcium : creatinine ratio &gt; 0.25 ) Current use medication know interfere vitamin D and/or calcium metabolism , include oral steroid anticonvulsant Ongoing recent ( past six month ) use bisphosphonates , estrogen compound , calcitonin teriparatide , compound may independently affect retention calcium within bone Diagnosis , evidence , osteomalacia , manifest serum 25 ( OH ) D &lt; 16 ng/ml presence least two follow blood test : low calcium , low phosphorus , elevate alkaline phosphatase ( 23 ) . Prior adult clinical fragility fracture baseline Tscore 3.0 lumbar spine femur</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Calcium Absorption</keyword>
	<keyword>Intestinal Absorption Calcium</keyword>
	<keyword>Fractional Calcium Absorption</keyword>
	<keyword>Stable Calcium Isotopes</keyword>
	<keyword>Hypovitaminosis D</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Bone Mineral Density</keyword>
	<keyword>Physical Function</keyword>
</DOC>